Berliner Boersenzeitung - Formerra to Supply Foster Medical Compounds in Europe

EUR -
AED 4.375983
AFN 78.643058
ALL 96.58421
AMD 452.507034
ANG 2.132979
AOA 1092.655973
ARS 1720.646167
AUD 1.702052
AWG 2.144799
AZN 1.994202
BAM 1.955357
BBD 2.405937
BDT 145.956951
BGN 2.001062
BHD 0.449262
BIF 3538.973885
BMD 1.191555
BND 1.511261
BOB 8.253339
BRL 6.188218
BSD 1.194505
BTN 109.898422
BWP 15.577453
BYN 3.374405
BYR 23354.481892
BZD 2.402437
CAD 1.611775
CDF 2689.940429
CHF 0.916201
CLF 0.025922
CLP 1023.546213
CNY 8.279404
CNH 8.277977
COP 4352.75114
CRC 591.052975
CUC 1.191555
CUP 31.576213
CVE 110.242351
CZK 24.327088
DJF 212.712547
DKK 7.467602
DOP 75.054029
DZD 154.184086
EGP 55.796005
ERN 17.873328
ETB 185.836015
FJD 2.618321
FKP 0.864594
GBP 0.866273
GEL 3.211194
GGP 0.864594
GHS 13.049374
GIP 0.864594
GMD 87.582685
GNF 10483.121962
GTQ 9.165117
GYD 249.899707
HKD 9.302168
HNL 31.52583
HRK 7.534919
HTG 156.585571
HUF 380.916966
IDR 19994.296232
ILS 3.686904
IMP 0.864594
INR 109.500169
IQD 1564.726005
IRR 50194.262927
ISK 144.999784
JEP 0.864594
JMD 187.430931
JOD 0.844788
JPY 183.319637
KES 154.03242
KGS 104.201491
KHR 4794.218086
KMF 490.920784
KPW 1072.479687
KRW 1714.177233
KWD 0.36539
KYD 0.995362
KZT 600.016586
LAK 25694.260282
LBP 106970.807356
LKR 369.567175
LRD 220.974601
LSL 18.847198
LTL 3.518353
LVL 0.720759
LYD 7.503679
MAD 10.816923
MDL 20.092052
MGA 5339.171934
MKD 61.662346
MMK 2502.757853
MNT 4250.149086
MOP 9.602805
MRU 47.653209
MUR 53.798635
MVR 18.421741
MWK 2071.27876
MXN 20.575658
MYR 4.697707
MZN 75.973614
NAD 18.845696
NGN 1659.098076
NIO 43.966502
NOK 11.444286
NPR 175.860008
NZD 1.96952
OMR 0.458172
PAB 1.19446
PEN 3.994496
PGK 5.191565
PHP 70.223095
PKR 334.136374
PLN 4.207078
PYG 8015.790446
QAR 4.354305
RON 5.096879
RSD 117.408628
RUB 89.657039
RWF 1742.807764
SAR 4.469232
SBD 9.624997
SCR 16.807192
SDG 716.736374
SEK 10.552627
SGD 1.509975
SHP 0.893975
SLE 28.955703
SLL 24986.315863
SOS 681.494305
SRD 45.283266
STD 24662.78687
STN 24.497948
SVC 10.451502
SYP 13178.09396
SZL 18.84092
THB 37.380873
TJS 11.156308
TMT 4.170443
TND 3.420697
TOP 2.868979
TRY 51.793571
TTD 8.107198
TWD 37.415189
TZS 3056.339186
UAH 51.122771
UGX 4249.144856
USD 1.191555
UYU 45.200714
UZS 14534.526007
VES 427.14412
VND 30897.026299
VUV 142.473093
WST 3.23723
XAF 655.79475
XAG 0.010764
XAU 0.000229
XCD 3.220237
XCG 2.152685
XDR 0.815673
XOF 655.841524
XPF 119.331742
YER 284.066617
ZAR 18.867019
ZMK 10725.425812
ZMW 23.621436
ZWL 383.680288
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    1.3800

    83.78

    +1.65%

  • CMSD

    0.0392

    24.09

    +0.16%

  • NGG

    0.3900

    85.07

    +0.46%

  • CMSC

    0.0100

    23.71

    +0.04%

  • BTI

    0.0600

    60.22

    +0.1%

  • AZN

    -0.6300

    92.59

    -0.68%

  • GSK

    0.5600

    50.66

    +1.11%

  • BP

    0.3400

    38.04

    +0.89%

  • BCE

    0.2200

    25.49

    +0.86%

  • RIO

    1.7600

    95.13

    +1.85%

  • RELX

    -1.2100

    36.17

    -3.35%

  • RYCEF

    -0.0700

    16.88

    -0.41%

  • BCC

    -0.5500

    80.3

    -0.68%

  • JRI

    -0.0500

    12.94

    -0.39%

  • VOD

    0.1400

    14.71

    +0.95%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

(A.Berg--BBZ)